首页 > 市场调查报告书 > 製药

生物製剂

市场调查报告书

商品编码

1672781

生物製药和生物医药市场：按产品类型、应用、类型、给药途径、患者人口统计和地区划分

Biopharmaceutical and Biomedicine Market, By Product Type, By Application, By Type, By Route of Administration, By Patient Demographics, By Geography

出版日期: 2025年02月06日 | 出版商:

Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球生物製药和生物医药市场规模估计为 6,4026 亿美元，预计到 2032 年将达到 14,251.7 亿美元，2025 年至 2032 年的复合年增长率为 12.1%。

报告范围		报告详细信息
基准年	2024	2025 年市场规模	6402.6亿美元
效能资料	从 2020 年到 2024 年	预测期	2025 至 2032 年
预测期：2025-2032年复合年增长率：	12.10％	2032 年价值预测	14,251.70亿美元

数字。 2025 年生物製药和生物医药市场区域份额（%）

过去几十年来，全球生物製药和生物医药市场经历了显着的成长。公共和私营部门不断增加对研发活动的投资，推动了生技药品、基因工程和开发新药领域的突破性创新。细胞和基因治疗、再生医学、单株抗体和个人化医疗等领域的进步为治疗慢性和危及生命的疾病提供了光明的前景。人口快速老化以及全球癌症、糖尿病和神经系统疾病盛行率的上升推动了对更有效治疗方案的需求。此外，合成生物学和基因工程的重大进展使科学家能够设计和开发先进的生技药品，如疫苗、荷尔蒙和血液成分，在医疗保健和其他工业领域具有重要应用。儘管成长机会仍然巨大，但高昂的研发成本和严格的法规仍然是个挑战。

市场动态：

推动全球生物製药和生物医药市场成长的关键因素包括慢性病和文明病的盛行率上升、易患各种健康问题的老年人口快速增加以及对优质医疗产品和服务的需求不断增加。此外，公私部门对先进蛋白质工程、重组DNA技术和干细胞研究的大量投资促进了新型生物药品和治疗方法的开发。然而，从临床试验到核准的药物开发成本极高，再加上敏感的製造流程和严格的法律规范，继续限制市场的快速扩张。同时，个人化医疗和组织器官3D生物列印的日益关注也为市场发展带来了新的途径。此外，研究机构和产业参与者之间的伙伴关係有助于加快有前景的候选药物的商业化并降低生产成本。

本研究的主要特点

本报告对全球生物製药和生物医药市场进行了详细分析，并展示了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%），以 2024 年为基准年。

它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，对全球生物製药和生物医药市场的主要企业进行分析。

主要企业包括诺华公司、强生公司、辉瑞公司、赛诺菲公司、礼来公司、罗氏公司、艾伯维公司、百时美施贵宝公司、Qiagen NV、Affimed NV、新基公司、安进公司、默克公司、葛兰素史克公司和再生元製药公司。

本报告的见解将帮助负责人和企业经营团队就未来产品发布、高端市场策略、市场扩张和行销策略做出明智的决策。

本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

相关人员将透过用于分析全球生物製药和生物医药市场的各种策略矩阵更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 640.26 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	12.10%	2032 Value Projection:	USD 1,425.17 Bn

The global biopharmaceutical and biomedicine market has witnessed tremendous growth over the past few decades. Rising investment in research and development activities by both public and private sectors has led to path breaking innovations in the field of biologics, genetic engineering and novel drug development. Advancements in areas such as cell and gene therapy, regenerative medicine, monoclonal antibodies and personalized medicine holds promising prospects for the treatment of chronic and life-threatening diseases. Rapidly aging population and growing incidence of cancer, diabetes and neurological disorders globally has spurred demand for more effective therapeutic options. Moreover, substantial progress in synthetic biology and genetic engineering is allowing scientists to design and develop advanced biologics like vaccines, hormones and blood components, with significant applications in healthcare and other industrial verticals. While growth opportunities remain vast, high R&D costs and stringent regulatory framework continue posing challenges.

Market Dynamics:

The key factors driving the growth of global biopharmaceutical and biomedicine market include rising prevalence of chronic and lifestyle diseases, rapid increase in geriatric population susceptible to various health issues, growing demand for superior healthcare products and services. Moreover, heavy investments by both public and private players in advanced protein engineering, recombinant DNA technology and stem cell research have enabled development of novel biologic drugs and therapies. However, extremely high costs associated with drug development from clinical trial to approval, coupled with delicate manufacturing processes and stringent regulatory oversight continue to restrain faster market expansion. At the same time, growing focus on personalized medicine and 3D bioprinting of tissues and organ present new avenues for market progress. In addition, partnerships between research institutes and industry players are helping accelerate commercialization of promising drug candidates and lower production costs.

Key Features of the Study:

This report provides in-depth analysis of the global biopharmaceutical and biomedicine market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global biopharmaceutical and biomedicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Novartis AG, Johnson & Johnson, Pfizer, Inc., Sanofi S.A., Eli Lilly and Company, Hoffmann-La Roche AG, AbbVie Inc., Bristol-Myers Squibb, Qiagen N.V., Affimed N.V., Celgene Corporation, Amgen Inc., Merck & Co., Inc., GSK Plc, and Regeneron Pharmaceuticals

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global biopharmaceutical and biomedicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biopharmaceutical and biomedicine market

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Biopharmaceuticals
- Monoclonal Antibodies
- Vaccines
- Recombinant Human Insulin
- Human Growth Hormone
- Erythropoietin
- Interferon
- Colony Stimulating Factor
- Blood Factors
- Fusion Protein
- Others
- Nanomedicine
- Cell & Gene Therapy
- Bioinformatics
- Molecular Enzymes & Kits
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Therapeutics
- Oncology
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Diseases
- Immune Disorders
- Diagnostics
- In Vitro Diagnostics
- In Vivo Diagnostics
- Point-of-Care Testing
- Research and Development
- Preclinical Research
- Clinical Trials
- Biotechnology Research
- Regulatory Research
Type Insights (Revenue, USD Bn, 2020 - 2032)
- Branded Biopharmaceuticals
- Generic Biopharmaceuticals
Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Intravenous
- Subcutaneous
- Intramuscular
Patient Demographics Insights (Revenue, USD Bn, 2020 - 2032)
- Adult
- Pediatric
- Geriatric
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Novartis AG
- Johnson & Johnson
- Pfizer, Inc.
- Sanofi S.A.
- Eli Lilly and Company
- Hoffmann-La Roche AG
- AbbVie Inc.
- Bristol-Myers Squibb
- Qiagen N.V.
- Affimed N.V.
- Celgene Corporation
- Amgen Inc.
- Merck & Co., Inc.
- GSK Plc
- Regeneron Pharmaceuticals

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Biopharmaceutical and Biomedicine Market, By Product Type
- Global Biopharmaceutical and Biomedicine Market, By Application
- Global Biopharmaceutical and Biomedicine Market, By Type
- Global Biopharmaceutical and Biomedicine Market, By Route of Administration
- Global Biopharmaceutical and Biomedicine Market, By Patient Demographics
- Global Biopharmaceutical and Biomedicine Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Biopharmaceutical and Biomedicine Market, By Product Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biopharmaceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Monoclonal Antibodies
- Vaccines
- Recombinant Human Insulin
- Human Growth Hormone
- Erythropoietin
- Interferon
- Colony Stimulating Factor
- Blood Factors
- Fusion Protein
- Others
Nanomedicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cell & Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Bioinformatics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Molecular Enzymes & Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Biopharmaceutical and Biomedicine Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oncology
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Diseases
- Immune Disorders
Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- In Vitro Diagnostics
- In Vivo Diagnostics
- Point-of-Care Testing
Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Preclinical Research
- Clinical Trials
- Biotechnology Research
- Regulatory Research

6. Global Biopharmaceutical and Biomedicine Market, By Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Branded Biopharmaceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Generic Biopharmaceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Biopharmaceutical and Biomedicine Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Biopharmaceutical and Biomedicine Market, By Patient Demographics, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Biopharmaceutical and Biomedicine Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa

10. Competitive Landscape

Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson
Pfizer, Inc.
Sanofi S.A.
Eli Lilly and Company
F.Hoffmann-La Roche AG
AbbVie Inc.
Bristol-Myers Squibb
Qiagen N.V.
Affimed N.V.
Celgene Corporation
Amgen Inc.
Merck & Co., Inc.
GSK Plc
Regeneron Pharmaceuticals

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

生物製药和生物医药市场：按产品类型、应用、类型、给药途径、患者人口统计和地区划分